The purpose of our research is to understand the status of the quality of life and level of disability acceptance in patients with facial burn scars and to explore the correlation between quality of life and disability acceptance and how to improve nursing care for these patients. Patients with facial burn scars were investigated in an outpatient clinic of tertiary hospitals from September 2015 to February 2016. A cross-sectional survey was conducted. The questionnaires used included demographic data and investigations using the burn scars table, Burn-Specific Health Scale-Brief (BSHS-B), and acceptance disability scale (ADS). Differences between participants in terms of demographic characteristics, quality of life, and disability acceptance were assessed using two-tailed independent t-tests. The total score of quality of life and disability acceptance in facial burn scar patients was 137.06 ± 17.05 and 185.68 ± 23.74, respectively. The results of Spearman correlation analysis showed that the overall quality of life score of facial burn scar patients was positively correlated with disability acceptance (r = 0.245, p = 0.007). The quality of life of facial burn scar patients will improve with the improvement of disability acceptance level. Therefore, medical staff can improve the quality of life of patients by improving their disability acceptance level.

Several studies have investigated the effectiveness and safety of nonvitamin K antagonist oral anticoagulants (NOACs) vs vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and liver disease. Herein, we conducted a meta‐analysis to compare the effect of NOACs with VKAs in patients with AF and liver disease. We also conducted a subsidiary analysis to compare the risk of liver injury between NOACs and VKA in AF patients. We systematically searched the PubMed and Embase databases from January 2009 to May 2020 for the relevant studies. Hazard ratios (HRs) with 95% confidence intervals (CIs) were selected and pooled using a random‐effects model. A total of six cohorts were included. Compared with VKA use, the use of NOACs was associated with reduced risks of stroke or systemic embolism (HR 0.68, 95% CI 0.49‐0.93), all‐cause death (HR 0.69, 95% CI 0.63‐0.75), and intracranial bleeding (HR 0.49, 95% CI 0.40‐0.59), whereas the outcomes of major bleeding (HR 0.72, 95% CI 0.51‐1.01) and gastrointestinal bleeding (HR 0.84, 95% CI 0.51‐1.36) were not significantly different between groups in AF patients with liver disease. Moreover, compared with VKA use, the use of NOACs was associated with a reduced risk of liver injury (HR 0.72, 95% CI 0.61‐0.84) in AF patients. Compared with VKAs, the use of NOACs was associated with reduced risks of stroke or systemic embolism, all‐cause death, and intracranial bleeding in AF patients with liver disease, and associated with a reduced risk of liver injury in AF patients.

No abstract

Objective. To observe the short-term and long-term curative effects of partial hepatectomy on ruptured hemorrhage of primary liver cancer after transcatheter arterial embolization (TAE). Methods. A total of 150 patients with primary liver cancer treated in the hospital were enrolled as research objects between February 2018 and February 2021, including 75 cases undergoing TAE in the TAE group and the other 75 cases undergoing elective partial hepatectomy after TAE in the combination group. The surgical related indexes (leaving bed time, discharge time, success rate of hemostasis, lesion clearance rate), mean arterial pressure (MAP), heart rate (HR), hemoglobin, and liver function indexes (serum alpha-fetoprotein (AFP), albumin (ALB), total bilirubin (TBIL)) before and after treatment, postoperative complications, survival rate, and recurrence rate at 1 year after surgery between the two groups were compared. Results. Compared with the TAE group, hospitalization time was shorter ( P < 0.05 ), the success rate of hemostasis and lesions clearance rate were higher in the combination group ( P < 0.05 ). After surgery, levels of HR and serum AFP were significantly decreased, while levels of MAP, hemoglobin, serum ALB, and TBIL were significantly increased in both groups. The levels of HR and serum AFP in the combination group were lower than those in the TAE group, while levels of MAP, hemoglobin, serum ALB, and TBIL were higher than those in the TAE group ( P < 0.05 ). There was no significant difference in the incidence of postoperative complications between the two groups ( P < 0.05 ). Compared with the TAE group, the recurrence rate was lower, and the survival rate was higher in the combination group at 1 year after surgery ( P < 0.05 ). Conclusion. Partial hepatectomy can effectively improve hemostatic effect and liver function in ruptured hemorrhage of primary liver cancer after TAE, increase survival rate, and reduce postoperative recurrence rate.

Ankylosing spondylitis (AS) is a chronic inflammatory disease which mainly involves the spine and sacroiliac joints, and in which the etiology remains unclear. The major clinical manifestations of AS include inflammatory back pain, morning stiffness, limited spinal activity, and even spinal deformity or ankylosis at the advanced stage. 1 The disease not only affects the joints and the spine but also presents with extra-articular manifestations, such as eye involvement and inflammatory bowel disease (IBD). Less commonly, AS patients may